EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players

Mona Kriti iD, Raj Ojha iD, Samradhi Singh iD, Devojit Kumar Sarma, Vinod Verma, Ashok Kumar Yadav, Ravinder Nagpal, Manoj Kumar iD

Phenomics · 2025-02 · 5 (1) · 51-64

DOI: 10.1007/s43657-024-00199-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phenomics, online erschienen am 07.04.2025. Verfasst von Mona Kriti und 7 weiteren Autor:innen. Beteiligte Einrichtung: ICMR- National Institute for Research in Environmental Health, Bhopal Bypass Road, Bhauri, Bhopal, 462030 Madhya Pradesh India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type-2 diabetes mellitus (T2DM) is a global epidemic with significant societal costs. The gut microbiota, including its metabolites, plays a pivotal role in maintaining health, while gut dysbiosis is implicated in several metabolic disorders, including T2DM. Although data exists on the relationship between the gut bacteriome and metabolic disorders, further attention is needed for the mycobiome and virome. Recent advancements have begun to shed light on these connections, offering potential avenues for preventive measures. However, more comprehensive investigations are required to untangle the interrelations between different microbial kingdoms and their role in T2DM development or mitigation. This review presents a simplified overview of the alterations in the gut bacteriome in T2DM and delves into the current understanding of the mycobiome and virome's role in T2DM, along with their interactions with the cohabiting bacteriome. Subsequently, it explores into the age-related dynamics of the gut microbiome and the changes observed in the microbiome composition with the onset of T2DM. Further, we explore the basic workflow utilized in gut microbiome studies. Lastly, we discuss potential therapeutic interventions in gut microbiome research, which could contribute to the amelioration of the condition, serve as preventive measures, or pave the way towards personalized medicine.

Schlagwörter

Stichwörter der Autor:innen

BacteriomeGut microbiomeMycobiomePhageomeType 2 diabetes mellitusVirome

Autor:innen und Institutionen

  • ICMR- National Institute for Research in Environmental Health, Bhopal Bypass Road, Bhauri, Bhopal, 462030 Madhya Pradesh India.
  • Stem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, 226014 Uttar Pradesh India.
  • Department of Zoology, Central University of Jammu, 181143 Jammu, India.
  • Department of Nutrition & Integrative Physiology, College of Health & Human Sciences, Florida State University, Tallahassee, FL 32306 USA.

ORCID-Profile: Mona Kriti, Raj Ojha, Samradhi Singh, Manoj Kumar

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Kriti, M., Ojha, R., Singh, S., Sarma, D. K., Verma, V., Yadav, A. K., Nagpal, R., & Kumar, M. (2025). Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players. Phenomics, 5(1), 51-64. https://doi.org/10.1007/s43657-024-00199-1

Vancouver

Kriti M, Ojha R, Singh S, Sarma DK, Verma V, Yadav AK, et al. Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players. Phenomics. 2025;5(1):51-64. doi:10.1007/s43657-024-00199-1

BibTeX
@article{Kriti2025,
  author = {Kriti, Mona and Ojha, Raj and Singh, Samradhi and Sarma, Devojit Kumar and Verma, Vinod and Yadav, Ashok Kumar and Nagpal, Ravinder and Kumar, Manoj},
  title = {Implication of Gut Mycobiome and Virome in Type-2 Diabetes Mellitus: Uncovering the Hidden Players},
  journal = {Phenomics},
  year = {2025},
  volume = {5},
  number = {1},
  pages = {51--64},
  doi = {10.1007/s43657-024-00199-1}
}
Kostenlos starten →